Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process

Medicine and Dentistry

• Prostate Cancer 100%
• Prognostic Factor 100%
• Diseases 33%
• Personalized Medicine 33%
• Decision Making 33%
• Biological Marker 33%
• Malignant Neoplasm 33%
• Gene 33%
• Circulating Tumor Cell 33%
• microRNA 33%
• Prostate Specific Antigen 33%
• Exosome 33%
• Urinary Tract Tumor 33%
• Gleason Score 33%
• Therapeutic Procedure 33%
• Patient 33%
• Death 33%
• Man 33%
• Prognosis 33%

Biochemistry, Genetics and Molecular Biology

• Decision Making 33%
• Nested Gene 33%
• MicroRNA 33%
• Prostate-Specific Antigen 33%
• Gleason Score 33%
• TMPRSS2 33%